TITLE

Review: Intensive insulin pump therapy slightly improves glycemic control in type 1 diabetes

AUTHOR(S)
Kudva, Yogish C.
PUB. DATE
September 2002
SOURCE
ACP Journal Club;Sep/Oct2002, Vol. 137 Issue 2, p56
SOURCE TYPE
Academic Journal
DOC. TYPE
Article
ABSTRACT
Compares the efficacy between continuous subcutaneous insulin infusion and multiple insulin injections for glycemic control in patients with type 1 diabetes mellitus. Meta-analysis of randomized controlled trials; Weighted mean differences in blood glucose level, glycated hemoglobin and total daily insulin dosage; Information on data sources and study selection.
ACCESSION #
7519813

 

Related Articles

  • Intensive glucose lowering (HbA1c target<6.0%) for people with type 2 diabetes increases mortality. Shaw, Jonathan E. // Evidence Based Medicine;Dec2011, Vol. 16 Issue 6, p186 

    The article presents a study that deals with long-term effects of intensive glucose lowering on cardiovascular outcomes. The study focuses on the Action to Control Cardiovascular Risk in Diabetes trial which aimed to address the uncertainty on the role of lowering blood glucose in reducing the...

  • Lower HbA1c linked with dramatically reduced risk of diabetes complications.  // Podiatry Now;Aug2013, Vol. 16 Issue 8, p12 

    The article discusses the results of the 2013 follow up of the Diabetes Control and Complications Trial that reveal 57 percent reduction in heart disease stroke and cardiovascular death, a 39 percent lower incidence of early signs of kidney damage, and a 46 percent lower risk in retinopathy.

  • Low-dose guar improves diabetic control. Jones, D. B.; Lousley, S.; Jelfs, R.; Slaughter, P.; Carter, R. D.; Mann, J. I. // Journal of the Royal Society of Medicine;Jul1985, Vol. 78 Issue 7, p546 

    Twenty diabetic outpatients (12 non-insulin-treated and 8 insulin-treated) were given guar granulate in a dose of 10 g daily for two months in order to study the effect on glycaemic control and lipid levels. Mean glycosylated haemoglobin levels (HbA1c%) fell from 1.1± 2.0% pre-guar to 10.5...

  • Multivariate analysis of glycosylated haemoglobin in insulin-treated diabetics. Child, D. F.; Wood, Jane; Hudson, P. R.; Williams, C. P.; Roberts, D. R.; Smith, C. // Journal of the Royal Society of Medicine;Jul1985, Vol. 78 Issue 7, p549 

    Glycosylated haemoglobin (HbA1), as an assessment of overall control, was estimated in 858 insulin-treated diabetics attending for changeover to U100 insulin in North East Wales. Details of age, sex, duration of diabetes, insulin regimen and monitoring method were recorded. Multivariate analysis...

  • Clinical Experience With the Addition of Pramlintide in Patients With Insulin-Requiring Type 2 Diabetes. Elkind-Hirsch, Karen; Butler, William J.; Bhushan, Madhu; Hirsch, David; Bhushan, Rajat // Diabetes Care;Jan2008, Vol. 31 Issue 1, p39 

    The article focuses on a study that involved adding pramlintide in patients with insulin-requiring type 2 diabetes. According to it, pramlintide added to insulin treatment in patients with type 2 diabetes was shown to reduce postprandial glucose levels, improve glycemic control, and promote...

  • Errata.  // Diabetes Care;Jan2009, Vol. 32 Issue 1, p207 

    Corrections to the articles that were published in previous issues are presented including "Association of 1,5-Anhydroglucitol and 2-h Postprandial Blood Glucose in Type 2 Diabetic Patients," by R. K. Schindhelm, M. Diamant, H. J. Bilo and R. J. Slingerland and "The A1c-Derived Average Glucose...

  • Multiple Daily SMBG Is Strongly Associated with Optimal Glucose Control in CSII Patients. Heinemann, Lutz; Renard, Eric; Grunder, Stefan; Buhr, Andreas; Schweitzer, Matthias A. // Diabetes;Jun2007 Supplement 1, Vol. 56, pA23 

    SMBG is a mandatory component of successful intensive diabetes management, specifically in insulin treated diabetic patients. However, limited data exist from clinical trials about the relationship between SMBG frequency and HbA1c outcome in CSII patients. In this international survey, questions...

  • Randomized Control Trial of Continuous Glucose Monitoring Devices on HbA1c--The MITRE Study. Newman, Stanton P.; Hurel, Steven J.; Cooke, Debbie; Steed, Elizabeth; Nunn, Andrew; Meredith, Sarah; Casbard, Angela // Diabetes;Jun2007 Supplement 1, Vol. 56, pA30 

    The article focuses on a randomized controlled trial of continuous glucose monitoring system (CGMS) on glycosylated hemoglobin. It mentions that this study aims to evaluate the efficacy of minimally invasive glucose monitoring devices in diabetics treated with insulin. It states that patients...

  • Real Life Data on the Switch from Nph to Glargine in Type 1 Diabetics. McEwan, Phil; Sharplin, Peter; Mehin, Nazanin; Tetlow, Tony // Diabetes;Jun2007 Supplement 1, Vol. 56, pA658 

    This study is a real life evaluation of glycemic control in Type 1 diabetes' patients who are introduced to insulin glargine therapy after switching from NPH therapy. Based on data from the THIN database (The Health Improvement Network), a UK GP database including 2,335,667 patients followed...

Share

Read the Article

Courtesy of VIRGINIA BEACH PUBLIC LIBRARY AND SYSTEM

Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics